Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
AI Medical Service Inc., Tokyo, Japan.
Gastrointest Endosc. 2019 Sep;90(3):407-414. doi: 10.1016/j.gie.2019.04.245. Epub 2019 May 8.
Cancer invasion depth is a critical factor affecting the choice of treatment in patients with superficial squamous cell carcinoma (SCC). However, the diagnosis of invasion depth is currently subjective and liable to interobserver variability.
We developed a deep learning-based artificial intelligence (AI) system based on Single Shot MultiBox Detector architecture for the assessment of superficial esophageal SCC. We obtained endoscopic images from patients with superficial esophageal SCC at our facility between December 2005 and December 2016.
After excluding poor-quality images, 8660 non-magnified endoscopic (non-ME) and 5678 ME images from 804 superficial esophageal SCCs with pathologic proof of cancer invasion depth were used as the training dataset, and 405 non-ME images and 509 ME images from 155 patients were selected for the validation set. Our system showed a sensitivity of 90.1%, specificity of 95.8%, positive predictive value of 99.2%, negative predictive value of 63.9%, and an accuracy of 91.0% for differentiating pathologic mucosal and submucosal microinvasive (SM1) cancers from submucosal deep invasive (SM2/3) cancers. Cancer invasion depth was diagnosed by 16 experienced endoscopists using the same validation set, with an overall sensitivity of 89.8%, specificity of 88.3%, positive predictive value of 97.9%, negative predictive value of 65.5%, and an accuracy of 89.6%.
This newly developed AI system showed favorable performance for diagnosing invasion depth in patients with superficial esophageal SCC, with comparable performance to experienced endoscopists.
癌症浸润深度是影响浅表性鳞状细胞癌(SCC)患者治疗选择的关键因素。然而,目前浸润深度的诊断是主观的,容易受到观察者间变异性的影响。
我们基于单阶段多盒探测器(Single Shot MultiBox Detector)架构开发了一个用于评估浅表性食管 SCC 的深度学习人工智能(AI)系统。我们从 2005 年 12 月至 2016 年 12 月在我们医院接受治疗的浅表性食管 SCC 患者中获取了内镜图像。
排除质量较差的图像后,使用 804 例具有癌症浸润深度病理证实的浅表性食管 SCC 的 8660 张非放大内镜(non-ME)和 5678 张 ME 图像作为训练数据集,并从 155 例患者中选择了 405 张 non-ME 图像和 509 张 ME 图像作为验证集。我们的系统在区分病理黏膜和黏膜下微浸润(SM1)癌与黏膜下深层浸润(SM2/3)癌方面,其敏感性为 90.1%,特异性为 95.8%,阳性预测值为 99.2%,阴性预测值为 63.9%,准确性为 91.0%。使用相同的验证集,16 名经验丰富的内镜医生诊断癌症浸润深度,其总体敏感性为 89.8%,特异性为 88.3%,阳性预测值为 97.9%,阴性预测值为 65.5%,准确性为 89.6%。
这个新开发的 AI 系统在诊断浅表性食管 SCC 患者的浸润深度方面表现出良好的性能,与经验丰富的内镜医生相当。